Oct 22, 2010, 12.45 PM IST | Source: Moneycontrol.com

KDL Biotech reports Rs 7.78 crore turnover for quarter ended Sep 2010

KDL Biotech has reported a sales turnover of Rs 7.78 crore and a net loss of Rs 3.50 crore for the quarter ended Sep 2010

KDL Biotech reports Rs 7.78 crore turnover for quarter ended Sep 2010
KDL Biotech has reported a sales turnover of Rs 7.78 crore and a net loss of Rs 3.50 crore for the quarter ended Sep 2010.
For the quarter ended Sep 2009 the sales turnover was Rs 5.72 crore and net profit was Rs 2.97 crore.
Quarterly Results of KDL Biotech-------- in Rs. Cr. --------
Sep '09Jun '10Sep '10
Sales Turnover5.726.937.78
Other Income0.140.110.13
Total Income5.867.057.91
Total Expenses7.027.298.10
Operating Profit-1.30-0.36-0.32
Profit On Sale Of Assets------
Profit On Sale Of Investments------
Gain/Loss On Foreign Exchange------
VRS Adjustment------
Other Extraordinary Income/Expenses------
Total Extraordinary Income/Expenses6.40----
Tax On Extraordinary Items------
Net Extra Ordinary Income/Expenses------
Gross Profit-1.16-0.25-0.19
Interest0.540.440.47
PBDT4.70-0.68-0.65
Depreciation1.732.832.85
Depreciation On Revaluation Of Assets------
PBT2.97-3.51-3.50
Tax------
Net Profit2.97-3.51-3.50
Prior Years Income/Expenses------
Depreciation for Previous Years Written Back/ Provided------
Dividend------
Dividend Tax------
Dividend (%)------
Earnings Per Share1.24----
Book Value------
Equity24.0424.0424.04
Reserves------
Face Value10.0010.0010.00
Source : Religare Technova
Set email alert for

ADS BY GOOGLE

Buy & sell politicians on Power Play
- the political stock exchange

Price Update

Arvind Kejriwal

1716.75 10.45 0.61%

129145

Bought today

86953

Sold today

1.59%

User holding

video of the day

Ambit Cap eyes two years of market cheer; bets on cyclicals

Explore Moneycontrol

Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.